Home » Stocks » BNTX

BioNTech SE (BNTX)

Stock Price: $168.95 USD 7.15 (4.42%)
Updated Apr 22, 2021 4:00 PM EDT - Market closed
Pre-market: $173.47 +4.52 (2.68%) Apr 23, 6:36 AM
Market Cap 37.72B
Revenue (ttm) 588.20M
Net Income (ttm) 18.53M
Shares Out 241.52M
EPS (ttm) 0.07
PE Ratio 2,308.98
Forward PE 16.72
Dividend n/a
Dividend Yield n/a
Trading Day April 22
Last Price $168.95
Previous Close $161.80
Change ($) 7.15
Change (%) 4.42%
Day's Open 164.99
Day's Range 164.80 - 176.00
Day's Volume 4,680,735
52-Week Range 43.00 - 176.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Money and pipelines are the two most important factors in picking the most likely to succeed.

Other stocks mentioned: MRNA, PFE
51 minutes ago - The Motley Fool

This small-cap biotech is currently trailing its rivals in the coronavirus vaccine race. Could a comeback be in the cards?

Other stocks mentioned: MRNA, PFE
1 day ago - The Motley Fool

AstraZeneca's pain is resulting in a big gain for Pfizer and BioNTech.

Other stocks mentioned: PFE
1 day ago - The Motley Fool

BioNTech's mRNA vaccine pioneer says third Pfizer dose is likely

YouTube video

CNBC's Kelly Evans discusses mass vaccination and fighting the Covid pandemic with Dr. Ozlem Tureci, BioNTech chief medical officer and co-founder. For access to live and exclusive video from CNBC subsc...

Other stocks mentioned: PFE
1 day ago - CNBC Television

The chief medical officer of BioNTech told CNBC that people will likely need a third shot of its two-dose Covid-19 vaccine as immunity against the virus wanes.

Other stocks mentioned: PFE
1 day ago - CNBC

EU says J&J vaccine benefits outweigh risks, plus Pfizer finds fake COVID-19 shots

YouTube video

Yahoo Finance's Anjalee Khemlani reports on European regulators finding a possible blood clot link with the Johnson & Johnson vaccine, but say the benefits outweigh the risks. Meanwhile, Pfizer identifi...

Other stocks mentioned: JNJ, PFE
1 day ago - Yahoo Finance

The European Commission exercises its option to purchase an additional 100 million doses of Pfizer (PFE)/ BioNTech's COVID-19 vaccine, Comirnaty, for EU member states.

Other stocks mentioned: PFE
2 days ago - Zacks Investment Research

NEW YORK and MAINZ, GERMANY, April 19, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the ...

4 days ago - GlobeNewsWire

Pfizer is a lot more than the covid vaccine. PFE stock has strong growth potential and is a great dividend stock for 2021.

Other stocks mentioned: PFE
6 days ago - InvestorPlace

Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline

YouTube video

Pfizer CEO sees need for a third vaccine dose as Moderna updates its timeline on third booster shot. Pause on the Johnson & Johnson vaccine remains.

Other stocks mentioned: PFE, MRNA
6 days ago - Yahoo Finance

Studies are still under way to determine whether additional booster shots are needed to maintain immunity, but Pfizer's CEO calls it "a likely scenario."

Other stocks mentioned: PFE
1 week ago - CNET

Pfizer to Raise EU Vaccine Supply by 25%

YouTube video

Apr.14 -- Eurasia Group Global Health Special Advisor Scott Rosenstein speaks to Bloomberg's and Alix Steel about Pfizer's increased vaccine supply and the vaccination rate in Europe on "Bloomberg Marke...

Other stocks mentioned: PFE
1 week ago - Bloomberg Markets and Finance

A comparison between COVID-19 vaccines of Pfizer (PFE)/BioNTech (BNTX), Moderna's (MRNA), AstraZeneca (AZN) and J&J (JNJ) is inevitable.

Other stocks mentioned: AZN, JNJ, MRNA, PFE
1 week ago - Zacks Investment Research

Millions of kids could soon be allowed to receive Pfizer's COVID-19 vaccine. Will the big drugmaker make some big bucks this year?

Other stocks mentioned: PFE
1 week ago - The Motley Fool

Bad news for J&J could be good news for these biotechs.

Other stocks mentioned: NVAX
1 week ago - The Motley Fool

Johnson & Johnson's (NYSE: JNJ) pain has proved to be gain for other vaccine companies, including BioNTech SE (NASDAQ: BNTX), Pfizer Inc. (NYSE: PFE), Moderna, Inc. (NASDAQ: MRNA) and Novavax, Inc. (NAS...

Other stocks mentioned: MRNA, NVAX, PFE
1 week ago - Benzinga

It can already claim it contributed to both companies' COVID vaccines.

Other stocks mentioned: MRNA, PFE
1 week ago - The Motley Fool

It's possible.

Other stocks mentioned: MRNA, PFE
1 week ago - The Motley Fool

According to a real-world data study in Israel, the coronavirus variant discovered in South Africa may dodge the protection provided by Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) COVID-19 vac...

Other stocks mentioned: PFE
1 week ago - Benzinga

Nearly everyone will get the Covid-19 vaccination, suggesting strong revenue for a handful of pharmaceutical companies. The post Vaccine Passport Potential Could Boost These 7 Pharmaceutical Stocks appe...

Other stocks mentioned: AZN, JNJ, MRNA, NVAX, PFE, REGN
1 week ago - InvestorPlace

South African Covid variant may evade the Pfizer vaccine, according to Israeli study

YouTube video

The coronavirus variant first discovered in South Africa may be able to evade some of the protection of the Pfizer-BioNTech vaccine, according to a new Israeli study. The researchers found the prevalenc...

Other stocks mentioned: PFE
1 week ago - CNBC Television

BioNTech SE Sponsored ADR (BNTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the ne...

1 week ago - Zacks Investment Research

The coronavirus variant first discovered in South Africa is able to evade some of the protection of the Pfizer-BioNTech vaccine, according to an Israeli study.

Other stocks mentioned: PFE
1 week ago - CNBC

If investors are expecting BNTX stock to continue generating double digit gains, they should be taking a careful look at its pipeline. The post What Can BioNTech Do for an Encore?

1 week ago - InvestorPlace

The European Commission is reportedly seeking EU governments' approval to get into talks with Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to purchase up to 1.8 billion doses of their COVID-19 ...

Other stocks mentioned: PFE
1 week ago - Benzinga

Pfizer files to expand Covid vaccine EUA down to age 12

YouTube video

CNBC's Meg Tirrell reports on Pfizer's latest filing to expand its vaccine authorization to adolescents.

Other stocks mentioned: PFE
1 week ago - CNBC Television

Regulatory and drug-pricing worries have knocked biotech stocks off their Covid-19 pedestal. After hitting a high point in early February, biotech stocks have collectedly fallen 21%.

Other stocks mentioned: ABBV, ACAD, ALXN, AZN, BIIB, CRSP, EDIT ...
1 week ago - Investors Business Daily

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

Other stocks mentioned: AZN, BBH, BTEC, FBT, IBB, MRNA, NVAX ...
2 weeks ago - Zacks Investment Research

There are several potential reasons why investors didn't cheer the companies' great news more loudly.

Other stocks mentioned: PFE
2 weeks ago - The Motley Fool

The National Institutes of Health (NIH) has begun a mid-stage study to determine the risk of allergic reactions shortly after receiving COVID-19 vaccines made by Moderna Inc (NASDAQ: MRNA) and Pfizer In...

Other stocks mentioned: MRNA, PFE
2 weeks ago - Benzinga

Look for sales of the vaccine to be better than expected, too.

Other stocks mentioned: PFE
2 weeks ago - The Motley Fool

Investors may be wondering what comes next for BioNTech SE (NASDAQ:BNTX). That is, what does the German company have behind its Covid-19 vaccine, which it says will generate revenue of $11.5 billion thi...

2 weeks ago - GuruFocus

Pfizer Inc (NYSE: PFE) is reportedly working on a new COVID-19 vaccine supply deal to Israel after an initial agreement announced in late 2020 has ended. “The company is currently working with the Israe...

Other stocks mentioned: PFE
2 weeks ago - Benzinga

Out of a limited number of earnings reports released in this shortened week, we'll recap here the impact of the week's five best reports.

Other stocks mentioned: ASO, CHWY, MU, WBA
2 weeks ago - 24/7 Wall Street

Pfizer's Covid-19 vaccine is effective against South African variant

YouTube video

CNBC's Meg Tirrell reports Pfizer's Covid-19 vaccine is effective against the more contagious South African Covid variant. Pfizer's vaccine is also effective for 6 months, according to clinical trials.

Other stocks mentioned: PFE
3 weeks ago - CNBC Television

Top-line results from clinical trials also show the jab protects against the so-called South African variant.

Other stocks mentioned: PFE
3 weeks ago - The Motley Fool

In a joint statement on Thursday, Pfizer Inc (NYSE: PFE) and BioNTech (NASDAQ: BNTX) said new data showed their Coronavirus vaccine had an efficacy of over 91% after six months. Initially, in November, ...

Other stocks mentioned: PFE
3 weeks ago - Invezz

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 2% after the company confirms high efficacy and no serious safety concerns through up to six months following the second dose in the updated...

Other stocks mentioned: SNAP
3 weeks ago - Benzinga

Pfizer and Biontech vaccines show strong efficacy against severe disease

YouTube video

#J&Jvaccine Yahoo Finance's Anjalee Khemlani and Myles Udland discuss the latest on Pfizer and Biontech showing strong efficacy against severe disease, plus a batch of Jonhson and Johnson COVID-19 vacci...

Other stocks mentioned: PFE
3 weeks ago - Yahoo Finance

Investors may want to consider the following securities as their forward price-earnings ratios are lower than the S&P 500's historical average of 15. The projections of future earnings are based on data...

Other stocks mentioned: ADM, MCK
3 weeks ago - GuruFocus

BioNTech stock continued a sprint Thursday after the company suggested its Pfizer-partnered Covid vaccine is effective against a mutation first identified in South Africa. The post Pfizer Suggests Covid...

Other stocks mentioned: PFE
3 weeks ago - Investors Business Daily

The shares of Pfizer Inc. (NYSE:PFE) are down 0.2% at $36.15 at last check, despite the drug maker posting updated results that showed its Covid-19 vaccine, in partnership with BioNTech (BNTX), is 91% e...

Other stocks mentioned: PFE
3 weeks ago - Schaeffers Research

The vaccine has been okayed for emergency use in the U.S. for people aged 16 or older.

Other stocks mentioned: PFE
3 weeks ago - Forbes

Pfizer (PFE) and BioNTech (BNTX) report 100% efficacy for their COVID-19 vaccine in teenagers aged 12 to 15.

Other stocks mentioned: PFE
3 weeks ago - Zacks Investment Research

New York and Mainz, Germany, April 1, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced updated topline results from analysis of 927 confirmed symptomatic cases of COVID-19 o...

3 weeks ago - GlobeNewsWire

Coronavirus: Pfizer says vaccine is 100% effective in kids 12-15, France goes into another lockdown

YouTube video

Yahoo Finance's Anjalee Khemlani reports on the latest coronavirus news including France going into another lockdown, US health officials voicing concern about a 4th wave, and Pfizer reporting COVID-19 ...

Other stocks mentioned: PFE
3 weeks ago - Yahoo Finance

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

Other stocks mentioned: PFE
3 weeks ago - Zacks Investment Research

The companies plan to apply for emergency use authorization in adolescents in the coming weeks.

Other stocks mentioned: PFE
3 weeks ago - The Motley Fool

The company and its partner Pfizer reported 100% efficacy for their COVID-19 vaccine in kids ages 12 to 15.

3 weeks ago - The Motley Fool

About BNTX

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small ce... [Read more...]

Industry
Biotechnology
IPO Date
Oct 10, 2019
Stock Exchange
NASDAQ
Ticker Symbol
BNTX
Full Company Profile

Financial Performance

Financial numbers in millions EUR.
Financial Statements

Analyst Forecasts

According to 10 analysts, the average rating for BioNTech SE stock is "Buy." The 12-month stock price forecast is 129.18, which is a decrease of -23.54% from the latest price.

Price Target
$129.18
(-23.54% downside)
Analyst Consensus: Buy